You are here: Industry Insights > Pre-IND

News List

Aptorum Group Announces Positive Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus americanpharmaceuticalreview
May 28, 2021
Aptorum Group Limited, a clinical-stage biopharmaceutical company, announces positive progress in respect of ...
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA americanpharmaceuticalreview
January 15, 2021
Amydis announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for its lead candidate, AMDX-2011P, a small-molecule retinal tracer that targets ...
FDA broadly supports Oragenics’ Pre-IND development programme for SARS-CoV-2 vaccine pharmaceutical-business-review
October 10, 2020
Oragenics, Inc. announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration (“FDA”) that it is in broad agreement with the Company’s planned approach to clinical development of its SARS-CoV-2 vaccine ...